RBCL (RBC Life Sciences) Pretax Margin %: -3.07% (As of Jun. 2017)


What is RBC Life Sciences Pretax Margin %?

RBC Life Sciences RBCL +0.14% Pretax Margin % is -3.07% as of Jun. 2017.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. RBC Life Sciences's Pre-Tax Income for the three months ended in Jun. 2017 was $-0.18 Mil. RBC Life Sciences's Revenue for the three months ended in Jun. 2017 was $5.74 Mil. Therefore, RBC Life Sciences's pretax margin for the quarter that ended in Jun. 2017 was -3.07%.

The historical rank and industry rank for RBC Life Sciences's Pretax Margin % or its related term are showing as below:


RBCL's Pretax Margin % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 4.665
* Ranked among companies with meaningful Pretax Margin % only.

RBC Life Sciences  (OTCPK:RBCL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

RBC Life Sciences Pretax Margin % Related Terms

RBC Life Sciences Pretax Margin % Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Pretax Margin % Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.34 -2.89 -2.55 -3.47 -2.58

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.66 4.01 -3.00 -0.68 -3.07

RBCL vs SKVI, TISUQ, TECR: Pretax Margin % Comparison

For the Household & Personal Products subindustry, RBC Life Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Life Sciences Pretax Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where RBC Life Sciences's Pretax Margin % falls into.


RBC Life Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

RBC Life Sciences's Pretax Margin for the fiscal year that ended in Dec. 2016 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-0.666/25.773
=-2.58 %

RBC Life Sciences's Pretax Margin for the quarter that ended in Jun. 2017 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2017 )/Revenue (Q: Jun. 2017 )
=-0.176/5.738
=-3.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -3.07% mean?
RBC Life Sciences (RBCL) has a Pretax Margin % of -3.07% as of Jun. 2017. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Pretax Margin % too high?
RBC Life Sciences' current Pretax Margin % is -3.07%.
How does RBC Life Sciences' Pretax Margin % compare to SKVI and TISUQ?
RBC Life Sciences' Pretax Margin % of -3.07% can be compared against companies in the Consumer Packaged Goods industry. The industry median Pretax Margin % is 4.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Consumer Packaged Goods company?
The median Pretax Margin % among Consumer Packaged Goods companies is 4.67, based on 1,952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on RBC Life Sciences and its competitors. For the Consumer Packaged Goods industry, the median Pretax Margin % is 4.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RBC Life Sciences's current Pretax Margin % is -3.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Pretax Margin % of -3.07%. The current Pretax Margin % is -3.07%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Pretax Margin % is -3.07% as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.